Ansell B, Beeson M, Hall P, Bedford P, Woo P (1993) HLA and juvenile psoriatic arthritis. Br J Rheumatol 32:836–837
PubMedCrossRefArora S, Singh N, Chaudhary GK, John MJ (2011) Autoimmune lymphoproliferative syndrome: response to mycophenolate mofetil and pyrimethamine/sulfadoxine in a 5-year-old child. Indian J Hematol Blood Transfus 27:101–103
PubMedPubMedCentralCrossRefArthur VL, Shuldiner E, Remmers EF, Hinks A, Grom AA, Foell D, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Oliveira S, Yeung RSM, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Szymanski AM, Incharge Consortium, Thomson W, Kastner DL, Woo P, Ombrello MJ (2018) IL1RN Variation influences both disease susceptibility and response to recombinant human interleukin-1 receptor antagonist therapy in systemic juvenile idiopathic arthritis. Arthritis Rheumatol 70:1319–1330
PubMedPubMedCentralCrossRefBarzaghi F, Amaya Hernandez LC, Neven B, Ricci S, Kucuk ZY, Bleesing JJ, Nademi Z, Slatter MA, Ulloa ER, Shcherbina A, Roppelt A, Worth A, Silva J, Aiuti A, Murguia-Favela L, Speckmann C, Carneiro-Sampaio M, Fernandes JF, Baris S, Ozen A, Karakoc-Aydiner E, Kiykim A, Schulz A, Steinmann S, Notarangelo LD, Gambineri E, Lionetti P, Shearer WT, Forbes LR, Martinez C, Moshous D, Blanche S, Fisher A, Ruemmele FM, Tissandier C, Ouachee-Chardin M, Rieux-Laucat F, Cavazzana M, Qasim W, Lucarelli B, Albert MH, Kobayashi I, Alonso L, Diaz De Heredia C, Kanegane H, Lawitschka A, Seo JJ, Gonzalez-Vicent M, Diaz MA, Goyal RK, Sauer MG, Yesilipek A, Kim M, Yilmaz-Demirdag Y, Bhatia M, Khlevner J, Richmond Padilla EJ, Martino S, Montin D, Neth O, Molinos-Quintana A, Valverde-Fernandez J, Broides A, Pinsk V, Ballauf A, Haerynck F, Bordon V, Dhooge C, Garcia-Lloret ML, Bredius RG, Kalwak K, Haddad E, Seidel MG, Duckers G, Pai SY, Dvorak CC, Ehl S, Locatelli F, Goldman F, Gennery AR, Cowan MJ, Roncarolo MG, Bacchetta R, Treatment CPID, Blood the Inborn Errors Working Party of the European Society for, and Transplantation Marrow (2018) Long-term follow-up of IPEX syndrome patients after different therapeutic strategies: An international multicenter retrospective study. J Allergy Clin Immunol 141(1036-49):e5
Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD (2001) The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27:20–21
PubMedCrossRefBettinardi A, Brugnoni D, Quiros-Roldan E, Malagoli A, La Grutta S, Correra A, Notarangelo LD (1997) Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 89:902–909
PubMedCrossRefBolze A, Byun M, McDonald D, Morgan NV, Abhyankar A, Premkumar L, Puel A, Bacon CM, Rieux-Laucat F, Pang K, Britland A, Abel L, Cant A, Maher ER, Riedl SJ, Hambleton S, Casanova JL (2010) Whole-exome-sequencing-based discovery of human FADD deficiency. Am J Hum Genet 87:873–881
PubMedPubMedCentralCrossRefBrunner HI, Ivaskova E, Haas JP, Andreas A, Keller E, Hoza J, Havelka S, Scholz S, Sierp G, Albert ED (1993) Class I associations and frequencies of class II HLA-DRB alleles by RFLP analysis in children with rheumatoid-factor-negative juvenile chronic arthritis. Rheumatol Int 13:83–88
PubMedCrossRefCanale VC, Smith CH (1967) Chronic lymphadenopathy simulating malignant lymphoma. J Pediatr 70:891–899
PubMedCrossRefChandran V, Schentag CT, Brockbank JE, Pellett FJ, Shanmugarajah S, Toloza SM, Rahman P, Gladman DD (2009) Familial aggregation of psoriatic arthritis. Ann Rheum Dis 68:664–667
PubMedCrossRefChun HJ, Zheng L, Ahmad M, Wang J, Speirs CK, Siegel RM, Dale JK, Puck J, Davis J, Hall CG, Skoda-Smith S, Atkinson TP, Straus SE, Lenardo MJ (2002) Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency. Nature 419:395–399
PubMedCrossRefDel-Rey M, Ruiz-Contreras J, Bosque A, Calleja S, Gomez-Rial J, Roldan E, Morales P, Serrano A, Anel A, Paz-Artal E, Allende LM (2006) A homozygous Fas ligand gene mutation in a patient causes a new type of autoimmune lymphoproliferative syndrome. Blood 108:1306–1312
PubMedCrossRefFechtenbaum M, Desoutter J, Delvallez G, Brochot E, Guillaume N, Goeb V (2019) MICA and NKG2D variants as risk factors in spondyloarthritis: a case-control study. Genes Immun 20:599–605
PubMedCrossRefFisher GH, Rosenberg FJ, Straus SE, Dale JK, Middleton LA, Lin AY, Strober W, Lenardo MJ, Puck JM (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81:935–946
PubMedCrossRefFitzGerald O, Haroon M, Giles JT, Winchester R (2015) Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype. Arthritis Res Ther 17:115
PubMedPubMedCentralCrossRefGambineri E, Ciullini Mannurita S, Hagin D, Vignoli M, Anover-Sombke S, DeBoer S, Segundo GRS, Allenspach EJ, Favre C, Ochs HD, Torgerson TR (2018) Clinical, immunological, and molecular heterogeneity of 173 patients with the phenotype of immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. Front Immunol 9:2411
PubMedPubMedCentralCrossRefGlerup M, Rypdal V, Arnstad ED, Ekelund M, Peltoniemi S, Aalto K, Rygg M, Toftedal P, Nielsen S, Fasth A, Berntson L, Nordal E, Herlin T, Rheumatology Nordic Study Group of Pediatric (2020) Long-term outcomes in juvenile idiopathic arthritis: eighteen years of follow-up in the population-based nordic juvenile idiopathic arthritis cohort. Arthritis Care Res (Hoboken) 72:507–516
CrossRefHaas JP, Grunke M, Frank C, Kolowos W, Dirnecker D, Leipold G, Hieronymus T, Lorenz HM, Herrmann M (1998) Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation. Cell Death Differ 5:751–757
PubMedCrossRefHaas JP, Nevinny-Stickel C, Schoenwald U, Truckenbrodt H, Suschke J, Albert ED (1994a) Susceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis. Hum Immunol 41:225–233
Haas JP, Truckenbrodt H, Paul C, Hoza J, Scholz S, Albert ED (1994b) Subtypes of HLA-DRB1*03, *08, *11, *12, *13 and *14 in early onset pauciarticular juvenile chronic arthritis (EOPA) with and without iridocyclitis. Clin Exp Rheumatol 12(Suppl 10):S7–S14
PubMedHinks A, Cobb J, Marion MC, Prahalad S, Sudman M, Bowes J, Martin P, Comeau ME, Sajuthi S, Andrews R, Brown M, Chen WM, Concannon P, Deloukas P, Edkins S, Eyre S, Gaffney PM, Guthery SL, Guthridge JM, Hunt SE, James JA, Keddache M, Moser KL, Nigrovic PA, Onengut-Gumuscu S, Onslow ML, Rose CD, Rich SS, Steel KJ, Wakeland EK, Wallace CA, Wedderburn LR, Woo P, J. I. A. Registry Boston Children’s, Paediatric British Society of, Group Adolescent Rheumatology Study, Study Childhood Arthritis Prospective, Study Childhood Arthritis Response to Medication, Rheumatology German Society for Pediatric, J. I. A. Gene Expression Study, Niams Jia Genetic Registry, Treat Study, Consortium United Kingdom Juvenile Idiopathic Arthritis Genetics, Bohnsack JF, Haas JP, Glass DN, Langefeld CD, Thomson W, Thompson SD (2013) Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis. Nat Genet 45:664–669
Hinks A, Marion MC, Cobb J, Comeau ME, Sudman M, Ainsworth HC, Bowes J, Immunochip Juvenile Idiopathic Arthritis Consortium for, Becker ML, Bohnsack JF, Haas JP, Lovell DJ, Mellins ED, Nelson JL, Nordal E, Punaro M, Reed AM, Rose CD, Rosenberg AM, Rygg M, Smith SL, Stevens AM, Videm V, Wallace CA, Wedderburn LR, Yarwood A, Yeung RSM, Langefeld CD, Thompson SD, Thomson W, Prahalad S (2018) Brief report: the genetic profile of rheumatoid factor-positive polyarticular juvenile idiopathic arthritis resembles that of adult rheumatoid arthritis. Arthritis Rheumatol 70:957–962
PubMedPubMedCentralCrossRefHinze C, Fuehner S, Kessel C, Wittkowski H, Lainka E, Baehr M, Hugle B, Haas JP, Ganser G, Weissbarth-Riedel E, Jansson A, Foell D (2020) Impact of IL1RN variants on response to interleukin-1 blocking therapy in systemic juvenile idiopathic arthritis. Arthritis Rheumatol 72(3):499–505
Holzelova E, Vonarbourg C, Stolzenberg MC, Arkwright PD, Selz F, Prieur AM, Blanche S, Bartunkova J, Vilmer E, Fischer A, Le Deist F, Rieux-Laucat F (2004) Autoimmune lymphoproliferative syndrome with somatic Fas mutations. N Engl J Med 351:1409–1418
PubMedCrossRefHuang X, Wang Z, Jia N, Shangguan S, Lai J, Cui X, Wu F, Wang L (2019) Association between STAT4 polymorphisms and the risk of juvenile idiopathic arthritis in Han Chinese populations. Clin Exp Rheumatol 37:333–337
PubMedHugle B, Schippers A, Fischer N, Ohl K, Denecke B, Ticconi F, Vastert B, Costa IG, Haas JP, Tenbrock K (2018) Transcription factor motif enrichment in whole transcriptome analysis identifies STAT4 and BCL6 as the most prominent binding motif in systemic juvenile idiopathic arthritis. Arthritis Res Ther 20:98
PubMedPubMedCentralCrossRefHusebye ES, Anderson MS, Kampe O (2018) Autoimmune polyendocrine syndromes. N Engl J Med 378:2543–2544
PubMedCrossRefKallinich T, Thorwarth A, von Stuckrad SL, Rosen-Wolff A, Luksch H, Hundsdoerfer P, Minden K, Krawitz P (2016) Juvenile arthritis caused by a novel FAMIN (LACC1) mutation in two children with systemic and extended oligoarticular course. Pediatr Rheumatol Online J 14:63
PubMedPubMedCentralCrossRefKasahara Y, Wada T, Niida Y, Yachie A, Seki H, Ishida Y, Sakai T, Koizumi F, Koizumi S, Miyawaki T, Taniguchi N (1998) Novel Fas (CD95/APO-1) mutations in infants with a lymphoproliferative disorder. Int Immunol 10:195–202
PubMedCrossRefKrumrey-Langkammerer M, Hafner R (2001) Evaluation of the ILAR criteria for juvenile idiopathic arthritis. J Rheumatol 28:2544–2547
PubMedLachmann HJ (2015) Autoinflammatory syndromes as causes of fever of unknown origin. Clin Med (Lond) 15:295–298
CrossRefLainka E, Haas JP, Horneff G, Weissbarth-Riedel E, Niehues T, Wittkowski H, Neudorf U (2013) Systemic juvenile idiopathic arthritis – new aspects of clinical features, diagnostic tools and treatment strategies. Ann Paediatr Rheumatol 2:3–13
Lampasona V, Passerini L, Barzaghi F, Lombardoni C, Bazzigaluppi E, Brigatti C, Bacchetta R, Bosi E (2013) Autoantibodies to harmonin and villin are diagnostic markers in children with IPEX syndrome. PLoS One 8:e78664
PubMedPubMedCentralCrossRefLuo Y, Chen J, Fang Y, Lou J, Yu J (2018) A case of metaplastic atrophic gastritis in immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. BMC Pediatr 18:191
PubMedPubMedCentralCrossRefMagerus-Chatinet A, Neven B, Stolzenberg MC, Daussy C, Arkwright PD, Lanzarotti N, Schaffner C, Cluet-Dennetiere S, Haerynck F, Michel G, Bole-Feysot C, Zarhrate M, Radford-Weiss I, Romana SP, Picard C, Fischer A, Rieux-Laucat F (2011) Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J Clin Invest 121:106–112
PubMedCrossRefMagerus-Chatinet A, Stolzenberg MC, Lanzarotti N, Neven B, Daussy C, Picard C, Neveux N, Desai M, Rao M, Ghosh K, Madkaikar M, Fischer A, Rieux-Laucat F (2013) Autoimmune lymphoproliferative syndrome caused by a homozygous null FAS ligand (FASLG) mutation. J Allergy Clin Immunol 131:486–490
PubMedCrossRefMcGonagle D, Aziz A, Dickie LJ, McDermott MF (2009) An integrated classification of pediatric inflammatory diseases, based on the concepts of autoinflammation and the immunological disease continuum. Pediatr Res 65:38R–45R
PubMedCrossRefMoroldo MB, Chaudhari M, Shear E, Thompson SD, Glass DN, Giannini EH (2004) Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. Arthritis Rheum 50:1928–1934
PubMedCrossRefNagamine K, Peterson P, Scott HS, Kudoh J, Minoshima S, Heino M, Krohn KJ, Lalioti MD, Mullis PE, Antonarakis SE, Kawasaki K, Asakawa S, Ito F, Shimizu N (1997) Positional cloning of the APECED gene. Nat Genet 17:393–398
PubMedCrossRefNeven B, Magerus-Chatinet A, Florkin B, Gobert D, Lambotte O, De Somer L, Lanzarotti N, Stolzenberg MC, Bader-Meunier B, Aladjidi N, Chantrain C, Bertrand Y, Jeziorski E, Leverger G, Michel G, Suarez F, Oksenhendler E, Hermine O, Blanche S, Picard C, Fischer A, Rieux-Laucat F (2011) A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 118:4798–4807
PubMedCrossRefNiemela J, Kuehn HS, Kelly C, Zhang M, Davies J, Melendez J, Dreiling J, Kleiner D, Calvo K, Oliveira JB, Rosenzweig SD (2015) Caspase-8 deficiency presenting as late-onset multi-organ lymphocytic infiltration with granulomas in two adult siblings. J Clin Immunol 35:348–355
PubMedPubMedCentralCrossRefOmbrello MJ, Arthur VL, Remmers EF, Hinks A, Tachmazidou I, Grom AA, Foell D, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JF, Ilowite NT, Mellins ED, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg AM, Wedderburn LR, Anton J, Haas JP, Rosen-Wolff A, Minden K, Tenbrock K, Demirkaya E, Cobb J, Baskin E, Signa S, Shuldiner E, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcon-Riquelme ME, Docampo E, Estivill X, Gul A, Pediatric British Society of, Inception Cohort of Newly Diagnosed Patients with Juvenile Idiopathic Arthritis Study Group Childhood Arthritis Prospective Study Group Randomized Placebo Phase Study of Rilonacept in sJIA Investigators Sparks-Childhood Arthritis Response to Medication Study Group Biologically Based Outcome Predictors in J. I. A. Group Adolescent Rheumatology Study Group, C. D. Langefeld, S. Thompson, E. Zeggini, D. L. Kastner, P. Woo, and W. Thomson (2017) Genetic architecture distinguishes systemic juvenile idiopathic arthritis from other forms of juvenile idiopathic arthritis: clinical and therapeutic implications. Ann Rheum Dis 76:906–913
PubMedCrossRefOmbrello MJ, Remmers EF, Tachmazidou I, Grom A, Foell D, Haas JP, Martini A, Gattorno M, Ozen S, Prahalad S, Zeft AS, Bohnsack JF, Mellins ED, Ilowite NT, Russo R, Len C, Hilario MO, Oliveira S, Yeung RS, Rosenberg A, Wedderburn LR, Anton J, Schwarz T, Hinks A, Bilginer Y, Park J, Cobb J, Satorius CL, Han B, Baskin E, Signa S, Duerr RH, Achkar JP, Kamboh MI, Kaufman KM, Kottyan LC, Pinto D, Scherer SW, Alarcon-Riquelme ME, Docampo E, Estivill X, Gul A, Pediatric British Society of, Group Adolescent Rheumatology Study, Group Childhood Arthritis Prospective Study, J. I. A. Investigators Randomized Placebo Phase Study of Rilonacept in s, Group Sparks-Childhood Arthritis Response to Medication Study, J. I. A. Group Biologically Based Outcome Predictors in, P. I. de Bakker, S. Raychaudhuri, C. D. Langefeld, S. Thompson, E. Zeggini, W. Thomson, D. L. Kastner, P. Woo, and Consortium International Childhood Arthritis Genetics (2015) HLA-DRB1*11 and variants of the MHC class II locus are strong risk factors for systemic juvenile idiopathic arthritis. Proc Natl Acad Sci U S A 112:15970–15975
PubMedPubMedCentralCrossRefOrlova EM, Bukina AM, Kuznetsova ES, Kareva MA, Zakharova EU, Peterkova VA, Dedov II (2010) Autoimmune polyglandular syndrome type 1 in Russian patients: clinical variants and autoimmune regulator mutations. Horm Res Paediatr 73:449–457
PubMedCrossRefPetty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, Maldonado-Cocco J, Suarez-Almazor M, Orozco-Alcala J, Prieur AM (1998) Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 25:1991–1994
PubMedPollock RA, Chandran V, Pellett FJ, Thavaneswaran A, Eder L, Barrett J, Rahman P, Farewell V, Gladman DD (2013) The functional MICA-129 polymorphism is associated with skin but not joint manifestations of psoriatic disease independently of HLA-B and HLA-C. Tissue Antigens 82:43–47
PubMedCrossRefPowell BR, Buist NR, Stenzel P (1982) An X-linked syndrome of diarrhea, polyendocrinopathy, and fatal infection in infancy. J Pediatr 100:731–737
PubMedCrossRefPrahalad S, McCracken CE, Ponder LA, Angeles-Han ST, Stevens KAR, Vogler LB, Langefeld CD, Thompson SD, Arthritis Childhood, and Investigators Rheumatology Research Alliance Registry (2016) Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry. Pediatr Rheumatol Online J 14:14
PubMedPubMedCentralCrossRefPrahalad S, Zeft AS, Pimentel R, Clifford B, McNally B, Mineau GP, Jorde LB, Bohnsack JF (2010) Quantification of the familial contribution to juvenile idiopathic arthritis. Arthritis Rheum 62:2525–2529
PubMedPubMedCentralCrossRefPuck JM, Zhu S (2003) Immune disorders caused by defects in the caspase cascade. Curr Allergy Asthma Rep 3:378–384
PubMedCrossRefRabionet R, Remesal A, Mensa-Vilaro A, Murias S, Alcobendas R, Gonzalez-Roca E, Ruiz-Ortiz E, Anton J, Iglesias E, Modesto C, Comas D, Puig A, Drechsel O, Ossowski S, Yague J, Merino R, Estivill X, Arostegui JI (2019) Biallelic loss-of-function LACC1/FAMIN mutations presenting as rheumatoid factor-negative polyarticular juvenile idiopathic arthritis. Sci Rep 9:4579
PubMedPubMedCentralCrossRefRao VK, Price S, Perkins K, Aldridge P, Tretler J, Davis J, Dale JK, Gill F, Hartman KR, Stork LC, Gnarra DJ, Krishnamurti L, Newburger PE, Puck J, Fleisher T (2009) Use of rituximab for refractory cytopenias associated with autoimmune lymphoproliferative syndrome (ALPS). Pediatr Blood Cancer 52:847–852
PubMedPubMedCentralCrossRefRieux-Laucat F, Le Deist F, Hivroz C, Roberts IA, Debatin KM, Fischer A, de Villartay JP (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268:1347–1349
PubMedCrossRefRieux-Laucat F, Magerus-Chatinet A, Neven B (2018) The autoimmune lymphoproliferative syndrome with defective FAS or FAS-ligand functions. J Clin Immunol 38:558–568
PubMedCrossRefSchaller JG, Ochs HD, Thomas ED, Nisperos B, Feigl P, Wedgwood RJ (1976) Histocompatibility antigens in childhood-onset arthritis. J Pediatr 88:926–930
PubMedCrossRefShah S, Wu E, Rao VK, Tarrant TK (2014) Autoimmune lymphoproliferative syndrome: an update and review of the literature. Curr Allergy Asthma Rep 14:462
PubMedPubMedCentralCrossRefShapiro RF, Wiesner KB, Bryan BL, Utsinger PD, Resnick D, Castles JJ (1976) HLA-B27 and modified bone formation. Lancet 1:230–231
PubMedCrossRefSingh A, Suri D, Vignesh P, Anjani G, Jacob P, Girisha KM (2020) LACC1 gene mutation in three sisters with polyarthritis without systemic features. Ann Rheum Dis 79:425–426
PubMedCrossRefSleight BJ, Prasad VS, DeLaat C, Steele P, Ballard E, Arceci RJ, Sidman CL (1998) Correction of autoimmune lymphoproliferative syndrome by bone marrow transplantation. Bone Marrow Transplant 22:375–380
PubMedCrossRefSneller MC, Straus SE, Jaffe ES, Jaffe JS, Fleisher TA, Stetler-Stevenson M, Strober W (1992) A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. J Clin Invest 90:334–341
PubMedPubMedCentralCrossRefThompson SD, Marion MC, Sudman M, Ryan M, Tsoras M, Howard TD, Barnes MG, Ramos PS, Thomson W, Hinks A, Haas JP, Prahalad S, Bohnsack JF, Wise CA, Punaro M, Rose CD, Pajewski NM, Spigarelli M, Keddache M, Wagner M, Langefeld CD, Glass DN (2012) Genome-wide association analysis of juvenile idiopathic arthritis identifies a new susceptibility locus at chromosomal region 3q13. Arthritis Rheum 64:2781–2791
PubMedPubMedCentralCrossRefThompson SD, Sudman M, Ramos PS, Marion MC, Ryan M, Tsoras M, Weiler T, Wagner M, Keddache M, Haas JP, Mueller C, Prahalad S, Bohnsack J, Wise CA, Punaro M, Zhang D, Rose CD, Comeau ME, Divers J, Glass DN, Langefeld CD (2010) The susceptibility loci juvenile idiopathic arthritis shares with other autoimmune diseases extend to PTPN2, COG6, and ANGPT1. Arthritis Rheum 62:3265–3276
PubMedPubMedCentralCrossRefThomschke S, Schulz M, Bätzing J (2018) Epidemiologie und Versorgung der juvenilen idiopathischen Arthritis (JIA) in der ambulanten Versorgung – eine Analyse anhand bundesweiter vertragsärztlicher Abrechnungsdaten der Jahre 2009 bis 2015. Versorgungsatlas-Bericht Nr. 18/10. Berlin 2018
Thorpe ES, Handley HE (1929) Chronic tetany and chronic mycelial stomatitis in a child aged four and one-half-years. Am J Dis Child 38:328–338
von Koskull S, Truckenbrodt H, Holle R, Hormann A (2001) Incidence and prevalence of juvenile arthritis in an urban population of southern Germany: a prospective study. Ann Rheum Dis 60:940–945
CrossRefWakil SM, Monies DM, Abouelhoda M, Al-Tassan N, Al-Dusery H, Naim EA, Al-Younes B, Shinwari J, Al-Mohanna FA, Meyer BF, Al-Mayouf S (2015) Association of a mutation in LACC1 with a monogenic form of systemic juvenile idiopathic arthritis. Arthritis Rheumatol 67:288–295
PubMedCrossRefWang J, Zheng L, Lobito A, Chan FK, Dale J, Sneller M, Yao X, Puck JM, Straus SE, Lenardo MJ (1999) Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell 98:47–58
PubMedCrossRefWu J, Wilson J, He J, Xiang L, Schur PH, Mountz JD (1996) Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease. J Clin Invest 98:1107–1113
PubMedPubMedCentralCrossRefZhu S, Hsu AP, Vacek MM, Zheng L, Schaffer AA, Dale JK, Davis J, Fischer RE, Straus SE, Boruchov D, Saulsbury FT, Lenardo MJ, Puck JM (2006) Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome. Hum Genet 119:284–294
PubMedCrossRef